AVIEW vs 1CMR Pro
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
AVIEW offers comprehensive AI solutions for CT scans, focusing on early detection and monitoring of lung conditions and coronary artery calcification. In contrast, 1CMR Pro specializes in AI-enhanced reporting and precise measurements from cardiac MRI scans. While both tools operate within cardiology and radiology, AVIEW addresses a broader range of CT-based diagnostics, whereas 1CMR Pro is dedicated to optimizing cardiac MRI analysis.
Choose AVIEW if…
Choose AVIEW if your institution requires a comprehensive AI platform for early detection, diagnosis, and monitoring of multiple thoracic conditions, including lung cancer, COPD, and coronary artery calcification, all from CT scans. It is ideal for radiology departments seeking to enhance diagnostic precision and streamline workflows across pulmonology and cardiology imaging with flexible deployment options.
View AVIEW →Choose 1CMR Pro if…
Choose 1CMR Pro if your cardiology department needs to significantly improve the precision, consistency, and speed of Cardiac MRI reporting through AI-enhanced volumetric and functional measurements. This tool is particularly well-suited for institutions prioritizing local data processing and regulatory-grade automation for robust and reproducible cardiac MRI analysis.
View 1CMR Pro →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AVIEW | 1CMR Pro |
|---|---|---|
| Pricing | Subscription; one-off payment | Contact for pricing |
| Deployment | Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker) | On-premise (software installed on hospital's own computer, processing data locally via a secure web-based platform) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AVIEW | 1CMR Pro |
|---|---|---|
| Tool Name | AVIEW | 1CMR Pro |
| Company | Coreline Soft Co. | Mycardium AI Limited |
| Tagline | AI-Driven Diagnostic Solutions for Medical Imaging | Revolutionizing Cardiac MRI with our FDA 510(k) cleared and CE Class IIB cleared analysis software, enhancing speed, accuracy and precision. |
| Primary Focus | Early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans | AI-enhanced Cardiac MRI reporting for faster and more consistent cardiac MRI analysis |
| Key Features (Examples) | AI-powered lung nodule detection and characterization; Emphysema quantification; Coronary artery calcium (CAC) scoring | AI-enhanced Cardiac MRI Reporting; Automated volumetric and functional measurements; Local data processing |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring AVIEW and 1CMR Pro.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
AVIEW is designed for workflow automation and integrates with PACS/RIS/CIS, aiming to streamline radiology workflows and consolidate multi-disease CT assessment into one pipeline. 1CMR Pro is installed on local hospital computers, processing data via a secure web-based platform, which implies integration with imaging systems, but its direct EHR integration depth is not explicitly detailed.
AVIEW enhances diagnostic precision for lung nodule detection and characterization, emphysema quantification, and coronary artery calcium scoring from CT scans, with reported high detection sensitivity and precision for nodules. 1CMR Pro delivers up to 40% more precise measurements for cardiac MRI analysis, with its AI models trained on extensive datasets and validated across multi-center datasets to improve consistency and accuracy.
AVIEW provides comprehensive solutions for lung cancer, COPD, and coronary artery calcification from CT scans, catering to Pulmonology, Cardiology, and Radiology with a broad range of features including ILD pattern analysis. 1CMR Pro specializes in AI-enhanced Cardiac MRI reporting, focusing specifically on Cardiology and Radiology for automated volumetric and functional measurements from cardiac MRI.
1CMR Pro emphasizes local data processing, ensuring no patient data is transmitted beyond the institution, and holds ISO 27001 certification. AVIEW's description mentions upgrades in security for its AVIEW 2.0 version to enhance data extraction and communication, but does not detail specific advanced security measures or audit-trail capabilities beyond general compliance.
1CMR Pro features transparent and editable contours, allowing clinicians control over the AI's analysis and promoting user confidence. AVIEW offers 3D visualizations and comprehensive PDF reports, which can aid in understanding and utilizing its diagnostic output, and its AVIEW 2.0 version includes UI/UX upgrades to improve intuitiveness.
AVIEW offers flexible deployment options including cloud-based, hybrid, and local solutions, and has been adopted in national-scale screening programs across multiple countries, indicating strong multi-site rollout and scalability support. 1CMR Pro's on-premise deployment with local data processing would require individual installations at each site, ensuring data remains within each institution, and it is built on foundational processes designed to scale with the company's product pipeline.